Genzyme Corp. et al v. Teva Pharmaceuticals USA, Inc. > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Aug 3, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [120] in Lead C.A. No. 18-1795-CFC. (fms) |
Feb 25, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel Minion for Genzyme Corp. and The Regents of the University of Michigan added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(ddp) |
Feb 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 2/12/2019. (fms) |
Feb 11, 2019 | 18 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
Feb 4, 2019 | 17 | Scheduling Order (11) Docket Text: SCHEDULING & CONSOLIDATION ORDER: THESE ACTIONS ARE CONSOLIDATED FOR ALL PURPOSES AND ALL PAPERS SHALL BE FILED IN CIV. NO. 18-1795-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/24/2020. Amended Pleadings due by 3/24/2020. Fact Discovery completed by 3/31/2020. A Markman Hearing is set for 1/22/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 3/11/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 3/22/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/31/2019. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(nmf) |
Feb 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Damien N. Dombrowski for Genzyme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(ceg) |
Feb 4, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(cak) |
Feb 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Katherine E. Adams for Genzyme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(ceg) |
Feb 4, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01795-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1795-CFC. (nmf) |
Feb 1, 2019 | 16 | Notice Requesting Removal of Co-Counsel (6) Docket Text: NOTICE requesting Clerk to remove Michael E. Furrow as co-counsel. Reason for request: no longer with Venable LLP. (Fahnestock, Derek) |
Jan 31, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 1/31/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(nmf) |
Jan 28, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference is rescheduled as a Telephonic Scheduling Conference for 1/31/2019 at 04:00 PM before Judge Colm F. Connolly per the parties Proposed Scheduling Order and Cover Letter filed today. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(nmf) |
Jan 28, 2019 | 15 | Proposed Order (11) Docket Text: PROPOSED ORDER /Proposed Scheduling Order by Genzyme Corp., The Regents of the University of Michigan. (Attachments: # (1) Cover Letter)(Fahnestock, Derek) |
Jan 28, 2019 | 15 | Cover Letter (1) |
Jan 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:18-cv-01838-CFC, 11 in 1:18-cv-01839-CFC, 13 in 1:18-cv-01796-CFC, 12 in 1:18-cv-01837-CFC) MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Michael E. Furrow, Daniel J. Minion, Damien N. Dombrowski and Katherine E. Adams of Venable LLP filed by The Regents of the University of Michigan, Genzyme Corp. Signed by Judge Colm F. Connolly on 1/11/2019. Associated Cases: 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(fms) |
Jan 11, 2019 | 14 | Order Setting Scheduling Conference (3) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 1/31/2019 at 04:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/11/2019. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(nmf) |
Jan 10, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Michael E. Furrow, Daniel J. Minion, Damien N. Dombrowski and Katherine E. Adams of Venable LLP - filed by Genzyme Corp., The Regents of the University of Michigan. (Fahnestock, Derek) |
Jan 3, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher J. Citro, Micah G. Rappazzo, Jeanna Wacker, Sam Kwon, and Jay P. Lefkowitz for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
Dec 28, 2018 | 11 | Answer to Counterclaim (21) Docket Text: ANSWER to [7] Answer to Complaint, Counterclaim by Genzyme Corp., The Regents of the University of Michigan.(Blumenfeld, Jack) |
Dec 28, 2018 | 12 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding proposed joint scheduling conference. (Blumenfeld, Jack) |
Dec 12, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Jay Lefkowitz, Jeanna Wacker, Sam Kwon, Christopher Citro, and Micah Rappazzo filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 12/12/2018. (fms) |
Dec 12, 2018 | 9 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before December 28, 2018, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/28/2018.) Signed by Judge Colm F. Connolly on 12/12/2018. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(nmf) |
Dec 12, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jay Lefkowitz, Jeanna Wacker, Sam Kwon, Christopher Citro, and Micah Rappazzo - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
Dec 7, 2018 | 7 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Dec 7, 2018 | 8 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
Nov 21, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC (rjb) |
Nov 16, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by The Regents of the University of Michigan, Genzyme Corp.. Teva Pharmaceuticals USA, Inc. served on 11/16/2018, answer due 12/7/2018. (Fahnestock, Derek) |
Nov 15, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 11/15/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
Nov 14, 2018 | 1 | Exhibit A-D (112) |
Nov 14, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aventis Inc., Corporate Parent Sanofi, Corporate Parent sanofi-aventis Amerique du Nord for Genzyme Corp. filed by Genzyme Corp.. (sar) |
Nov 14, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,196,205 B2 ;6,916,802 B2 ;7,253,185 B2 ;7,615,573 B2. (sar) |
Nov 14, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 10, 2018. Date of Expiration of Patent: *SEE LIST*.Thirty Month Stay Deadline: 2/19/2022. (sar) |
Nov 14, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
Nov 14, 2018 | 1 | Civil Cover Sheet (1) |
Nov 14, 2018 | 1 | Complaint* (1) |